Nephrogenic systemic fibrosis (NSF) is a fibrosing disorder, recently described in patients with advanced chronic kidney disease, usually after exposure to gadolinium (Gd)-based contrast agents, characterized by progressive fibrotic involvement mainly of the skin. At clinical examination, the cutaneous findings of NSF may partly resemble those of systemic sclerosis. However, the different topographic distribution of the skin thickening and hardening, usually involving the limbs and trunk, whilst sparing the face, the lack of serologic abnormalities and the distinctive histopathological findings allow this new disease entity to be distinguished from systemic sclerosis and other scleroderma-like fibrosing disorders (scleromyxedema, scleredema, eosinophilic fasciitis, etc.). Herein, we describe what, to best of our knowledge, is the first, biopsy proven, Italian case of NSF, which highlights the issue of the differential diagnosis between NSF and scleroderma-like fibrosing disorders.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00296-009-1083-4DOI Listing

Publication Analysis

Top Keywords

scleroderma-like fibrosing
12
nephrogenic systemic
8
systemic fibrosis
8
fibrosing disorder
8
systemic sclerosis
8
fibrosing disorders
8
fibrosis unusual
4
unusual scleroderma-like
4
fibrosing
4
disorder nephrogenic
4

Similar Publications

Phenotypical and biochemical characterization of murine psoriasiform and fibrotic skin disease models in Stabilin-deficient mice.

FEBS Open Bio

September 2024

Department of Dermatology, Venereology, and Allergology, University Medical Center and Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.

Stabilin-1 (Stab1) and Stabilin-2 (Stab2) are scavenger receptors expressed by liver sinusoidal endothelial cells (LSECs). The Stabilin-mediated scavenging function is responsible for regulating the molecular composition of circulating blood in mammals. Stab1 and Stab2 have been shown to influence fibrosis in liver and kidneys and to modulate inflammation in atherosclerosis.

View Article and Find Full Text PDF

Scleroderma and scleroderma-like syndromes.

Front Immunol

June 2024

Department of Connective Tissue Diseases, National Institute of Geriatrics, Rheumatology and Rehabilitation, Warsaw, Poland.

Systemic sclerosis is a systemic connective tissue disease whose main pathophysiological mechanism is a progressive fibrosis of internal organs and skin leading to thickening and induration. Blood vessels may also be involved. However, systemic scleroderma is not the only disease causing cutaneous sclerosis.

View Article and Find Full Text PDF

Immunologic and nonimmunologic sclerodermal skin conditions - review.

Front Immunol

February 2024

Multidisciplinary Integrated Center of Dermatological Interface Research MIC-DIR (Centrul Integrat Multidisciplinar de Cercetare de Interfata Dermatologica - CIM-CID), "Dunărea de Jos" University, Galaţi, Romania.

Article Synopsis
  • * These lesions have been linked to autoimmune diseases (like generalized morphea and chronic graft versus host disease), tissue storage diseases, metabolic disorders, and some progeroid syndromes.
  • * Accurate diagnosis is crucial for distinguishing these lesions from each other to ensure the right treatment is administered.
View Article and Find Full Text PDF

Scleroderma-Like Lupus Panniculitis: A Case Report and Literature Review.

Clin Cosmet Investig Dermatol

April 2023

Division of Dermatology, Department of Medicine, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.

Sclerodermic or scleroderma-like lupus erythematosus panniculitis (SLEP) shares both clinical and histopathological features between lupus panniculitis and localized scleroderma. It is exceedingly rare. We herein report a case of SLEP manifested with a solitary, firm-to-hard, erythematous plaque in an Asian woman.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!